Corcept Therapeutics (STU:HTD) Book Value per Share : €4.85 (As of Mar. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Corcept Therapeutics Book Value per Share?

Corcept Therapeutics's book value per share for the quarter that ended in Mar. 2024 was €4.85.

During the past 12 months, Corcept Therapeutics's average Book Value Per Share Growth Rate was 7.60% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 3.00% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 13.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the book value growth rate using book value per share data.

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Corcept Therapeutics was 142.10% per year. The lowest was -43.10% per year. And the median was 12.70% per year.

Corcept Therapeutics's current price is €25.74. Its book value per share for the quarter that ended in Mar. 2024 was €4.85. Hence, today's PB Ratio of Corcept Therapeutics is 5.31.

During the past 13 years, the highest P/B Ratio of Corcept Therapeutics was 86.18. The lowest was 3.17. And the median was 6.16.

Corcept Therapeutics Book Value per Share Historical Data

The historical data trend for Corcept Therapeutics's Book Value per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Corcept Therapeutics Book Value per Share Chart

Corcept Therapeutics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Book Value per Share

Get a 7-Day Free Trial

2.92

3.69

3.14

4.39

4.49

Corcept Therapeutics Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Book Value per Share	Get a 7-Day Free Trial															4.57	3.80	4.20	4.49	4.85

Competitive Comparison of Corcept Therapeutics's Book Value per Share

For the Biotechnology subindustry, Corcept Therapeutics's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Corcept Therapeutics's PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Corcept Therapeutics's PB Ratio distribution charts can be found below:

* The bar in red indicates where Corcept Therapeutics's PB Ratio falls into.

Corcept Therapeutics Book Value per Share Calculation

Corcept Therapeutics's Book Value Per Share for the fiscal year that ended in Dec. 2023 is calculated as:

Book Value Per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(464.6	-	0.0)	/	103.4
	=	4.49

Corcept Therapeutics's Book Value Per Share for the quarter that ended in Mar. 2024 is calculated as:

Book Value Per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(504.0	-	0.0)	/	104.0
	=	4.85

Theoretically it is what the shareholders will receive if the company is liquidated. Total Stockholders Equity is a balance sheet item and equal to Total Assets less Total Liabilities of the company.

Book value may include intangible items which may come from the company's past acquisitions. Book value less intangibles is called Tangible Book.

Corcept Therapeutics (STU:HTD) Book Value per Share Explanation

Usually a company's book value and Tangible Book per Share may not reflect its true value. The assets may be carried on the balance sheets at the original cost minus depreciation. This may underestimate the true economic values of the assets. It also may over-estimate their true economic value because the assets can become obsolete.

For financial companies such as banks and insurance companies, their assets may be reported in current market value of the assets owned. Book values of financial companies are more accurate indicator of the economic value of the company.

Corcept Therapeutics Book Value per Share Related Terms

Thank you for viewing the detailed overview of Corcept Therapeutics's Book Value per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Corcept Therapeutics (STU:HTD) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Corcept Therapeutics Inc (STU:HTD) » Definitions » Book Value per Share

Comparable Companies

Traded in Other Exchanges

CORT:USA HTD:Germany

Address

149 Commonwealth Drive, Menlo Park, CA, USA, 94025

Website

https://www.corcept.com

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol.